The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Animal Blood Plasma and Derivatives Market Research Report 2025
Synopsis
The global Animal Blood Plasma and Derivatives market was valued at US$ 998.3 million in 2023 and is anticipated to reach US$ 1403.5 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 220%.
This report aims to provide a comprehensive presentation of the global market for Animal Blood Plasma and Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Blood Plasma and Derivatives.
Report Scope
The Animal Blood Plasma and Derivatives market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Blood Plasma and Derivatives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Blood Plasma and Derivatives companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.
Segment by Type
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Thrombin
New Born Calf Serum
Segment by Application
Food & Beverages
Pharmaceuticals
Cosmetics
Feed
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Blood Plasma and Derivatives companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Animal Blood Plasma and Derivatives market was valued at US$ 998.3 million in 2023 and is anticipated to reach US$ 1403.5 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 220%.
This report aims to provide a comprehensive presentation of the global market for Animal Blood Plasma and Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Blood Plasma and Derivatives.
Report Scope
The Animal Blood Plasma and Derivatives market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Blood Plasma and Derivatives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Blood Plasma and Derivatives companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.
Segment by Type
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Thrombin
New Born Calf Serum
Segment by Application
Food & Beverages
Pharmaceuticals
Cosmetics
Feed
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Blood Plasma and Derivatives companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunoglobulin
1.2.3 Fibrinogen
1.2.4 Serum Albumin
1.2.5 Fetal Bovine Serum
1.2.6 Thrombin
1.2.7 New Born Calf Serum
1.3 Market by Application
1.3.1 Global Animal Blood Plasma and Derivatives Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Food & Beverages
1.3.3 Pharmaceuticals
1.3.4 Cosmetics
1.3.5 Feed
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Blood Plasma and Derivatives Market Perspective (2019-2030)
2.2 Animal Blood Plasma and Derivatives Growth Trends by Region
2.2.1 Global Animal Blood Plasma and Derivatives Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Animal Blood Plasma and Derivatives Historic Market Size by Region (2019-2024)
2.2.3 Animal Blood Plasma and Derivatives Forecasted Market Size by Region (2025-2030)
2.3 Animal Blood Plasma and Derivatives Market Dynamics
2.3.1 Animal Blood Plasma and Derivatives Industry Trends
2.3.2 Animal Blood Plasma and Derivatives Market Drivers
2.3.3 Animal Blood Plasma and Derivatives Market Challenges
2.3.4 Animal Blood Plasma and Derivatives Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Blood Plasma and Derivatives Players by Revenue
3.1.1 Global Top Animal Blood Plasma and Derivatives Players by Revenue (2019-2024)
3.1.2 Global Animal Blood Plasma and Derivatives Revenue Market Share by Players (2019-2024)
3.2 Global Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Animal Blood Plasma and Derivatives Revenue
3.4 Global Animal Blood Plasma and Derivatives Market Concentration Ratio
3.4.1 Global Animal Blood Plasma and Derivatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Blood Plasma and Derivatives Revenue in 2023
3.5 Animal Blood Plasma and Derivatives Key Players Head office and Area Served
3.6 Key Players Animal Blood Plasma and Derivatives Product Solution and Service
3.7 Date of Enter into Animal Blood Plasma and Derivatives Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Blood Plasma and Derivatives Breakdown Data by Type
4.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Type (2019-2024)
4.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Type (2025-2030)
5 Animal Blood Plasma and Derivatives Breakdown Data by Application
5.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Application (2019-2024)
5.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Animal Blood Plasma and Derivatives Market Size (2019-2030)
6.2 North America Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Animal Blood Plasma and Derivatives Market Size by Country (2019-2024)
6.4 North America Animal Blood Plasma and Derivatives Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Blood Plasma and Derivatives Market Size (2019-2030)
7.2 Europe Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Animal Blood Plasma and Derivatives Market Size by Country (2019-2024)
7.4 Europe Animal Blood Plasma and Derivatives Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Blood Plasma and Derivatives Market Size (2019-2030)
8.2 Asia-Pacific Animal Blood Plasma and Derivatives Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2019-2024)
8.4 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Blood Plasma and Derivatives Market Size (2019-2030)
9.2 Latin America Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Animal Blood Plasma and Derivatives Market Size by Country (2019-2024)
9.4 Latin America Animal Blood Plasma and Derivatives Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Blood Plasma and Derivatives Market Size (2019-2030)
10.2 Middle East & Africa Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2019-2024)
10.4 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Proliant Inc.
11.1.1 Proliant Inc. Company Detail
11.1.2 Proliant Inc. Business Overview
11.1.3 Proliant Inc. Animal Blood Plasma and Derivatives Introduction
11.1.4 Proliant Inc. Revenue in Animal Blood Plasma and Derivatives Business (2019-2024)
11.1.5 Proliant Inc. Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Detail
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Introduction
11.2.4 Thermo Fisher Scientific, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2019-2024)
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Animal Blood Plasma and Derivatives Introduction
11.3.4 Merck KGaA Revenue in Animal Blood Plasma and Derivatives Business (2019-2024)
11.3.5 Merck KGaA Recent Development
11.4 Kraeber & Co GmbH
11.4.1 Kraeber & Co GmbH Company Detail
11.4.2 Kraeber & Co GmbH Business Overview
11.4.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Introduction
11.4.4 Kraeber & Co GmbH Revenue in Animal Blood Plasma and Derivatives Business (2019-2024)
11.4.5 Kraeber & Co GmbH Recent Development
11.5 LAMPIRE Biological Laboratories, Inc.
11.5.1 LAMPIRE Biological Laboratories, Inc. Company Detail
11.5.2 LAMPIRE Biological Laboratories, Inc. Business Overview
11.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Introduction
11.5.4 LAMPIRE Biological Laboratories, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2019-2024)
11.5.5 LAMPIRE Biological Laboratories, Inc. Recent Development
11.6 Lake Immunogenics, Inc.
11.6.1 Lake Immunogenics, Inc. Company Detail
11.6.2 Lake Immunogenics, Inc. Business Overview
11.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Introduction
11.6.4 Lake Immunogenics, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2019-2024)
11.6.5 Lake Immunogenics, Inc. Recent Development
11.7 Rocky Mountain Biologicals Inc.
11.7.1 Rocky Mountain Biologicals Inc. Company Detail
11.7.2 Rocky Mountain Biologicals Inc. Business Overview
11.7.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Introduction
11.7.4 Rocky Mountain Biologicals Inc. Revenue in Animal Blood Plasma and Derivatives Business (2019-2024)
11.7.5 Rocky Mountain Biologicals Inc. Recent Development
11.8 ANZCO Foods Ltd.
11.8.1 ANZCO Foods Ltd. Company Detail
11.8.2 ANZCO Foods Ltd. Business Overview
11.8.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Introduction
11.8.4 ANZCO Foods Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2019-2024)
11.8.5 ANZCO Foods Ltd. Recent Development
11.9 Auckland BioSciences Ltd.
11.9.1 Auckland BioSciences Ltd. Company Detail
11.9.2 Auckland BioSciences Ltd. Business Overview
11.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Introduction
11.9.4 Auckland BioSciences Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2019-2024)
11.9.5 Auckland BioSciences Ltd. Recent Development
11.10 Bovogen Biologicals Pty Ltd.
11.10.1 Bovogen Biologicals Pty Ltd. Company Detail
11.10.2 Bovogen Biologicals Pty Ltd. Business Overview
11.10.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Introduction
11.10.4 Bovogen Biologicals Pty Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2019-2024)
11.10.5 Bovogen Biologicals Pty Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
